Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

CME Group (CME) Prices $1.2 Billion Senior Unsecured Notes

Published 06/14/2018, 10:49 PM
Updated 07/09/2023, 06:31 AM

CME Group (NASDAQ:CME) recently announced the pricing of $1.2 billion senior notes. The notes will be issued in two tranches, 3.75% $500 million senior unsecured notes due 2028 and 4.15% $700 million senior unsecured notes due 2048.

The company intends to deploy the proceeds from this offering along with cash in hand to finance the cash consideration of NEX Group plc by CME Group and CME London Limited.

CNA Financial’s debt-to-equity ratio at first-quarter end was 10.2%, having improved 70 basis points from 2017-end level. With this new issuance, the ratio is expected to deteriorate 530 basis points. Nonetheless, the leverage ratio will still compare favorably with the industry average of 20.6%.

However, with the new issuance, interest expense will increase. But we still believe in the company’s strong position to clear debts, banking on operational efficiencies, largely driven by organic growth.

Though the interest rate is gradually improving, reflecting the country’s thriving economy, the rate is still low. With the last one-quarter percentage point hike, the interest rate currently stands at 2%. Projections at the June FOMC meeting indicate interest rate to reach 3.4% at 2020 end as GDP grows at 2% and inflation remaining at 2.1% in 2020.

It seems a prudent approach on CME Group’s part to capitalize on the persistently low interest rate environment to procure funds. Also, lower interest rate reducing interest burden on borrowings combined with lower tax incidence should facilitate margin expansion.

Shares of CME Group have rallied 16.5% year to date, outperforming the industry’s growth of 9.9%. Efforts to expand and cross-sell through strategic alliances, acquisitions, new product initiatives and a consolidated global presence should drive growth for the company, pushing up its shares.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

CME Group has a Zacks Rank #3 (Hold).

Stocks to Consider

Some better-ranked stocks from the finance sector are Nasdaq, Inc. (NASDAQ:NDAQ) , AllianceBernstein Holding L.P. (NYSE:AB) and American Equity Investment Life Holding Company (NYSE:AEL) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Nasdaq delivered an average four-quarter positive surprise of 4.8%.

AllianceBernstein, a publicly owned investment manager, provides research services to its clients. The company pulled off an average four-quarter earnings surprise of 9.64%.

American Equity Investment provides life insurance products and services in the United States. The company came up with an average four-quarter beat of 24.38%.

Wall Street’s Next Amazon (NASDAQ:AMZN)

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>



AllianceBernstein Holding L.P. (AB): Free Stock Analysis Report

American Equity Investment Life Holding Company (AEL): Free Stock Analysis Report

CME Group Inc. (CME): Free Stock Analysis Report

Nasdaq, Inc. (NDAQ): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.